Remove Regulation Remove Trial Funding Remove Trials Remove Vaccine
article thumbnail

Regeneron and Lilly post new data backing COVID antibody cocktails

pharmaphorum

Regeneron is considering an emergency filing for its antibody cocktail REGEN-COV to protect people against COVID-19 after early trial results showed it conferred 100% protection against symptomatic infection.